trump on glp-1 The administration announced deals that will lower the prices of major obesity drugs for many Americans. Under the deals with Eli Lilly and Novo Nordisk, those buying injectable President Donald Trump announced Thursday

As the role of obesity in diseases ranging form Prader-Willi syndrome to cardiovascular disease becomes increasingly clear, the potential impact of GLP-1 receptor agonists extends far beyond weight loss alone

Learn More Anti-Vaping Initiative Through campaign efforts and educational initiatives, we are increasing awareness on the negative impacts of vaping among Louisianas youth

We'll set aside compounding for a minute, but let's assume we're getting the actual drug and just getting it because I know I'm heavy and I know that I've exercised and it doesn't really work, and maybe I just want to take it for 6 months and shed the 10 pounds

Caccamo, M